Share this site with others using one of these sharing tools.
To link to this article, paste this block of HTML code onto your webpage.
Guidelines for sites linking to mayoclinic.orgBelow is a list of Neurofibromatosis Type 2 clinical trials from the clinical trials database at Mayo Clinic.
Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. Patients should ask their doctor at Mayo about clinical trials appropriate for their situation.
AZD2171 in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibroma and/or Neurofibroma Near the Spine
OBJECTIVES: Primary - Assess the efficacy of AZD2171, in terms of volume change in target tumors by 3-dimensional (3D) MRI in patients with neurofibromatosis type 1 and extensive plexiform and/or paraspinal neurofibromas. - Describe and define the toxicities of AZD2171 in these patients.
Read more
.
Find Mayo Clinic on